Clinical Trial Update: Xeltis Hemodialysis Access Graft (aXess) US Study [NA]

View source ↗

Summary

Clinical trial update indicating that Xeltis's aXess hemodialysis access graft US study is currently enrolling by invitation for patients with End-Stage Renal D…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• aXess Hemodialysis Access Graft (aXess graft)

Snippet

Sponsor: Xeltis | Conditions: End Stage Renal Disease | NA | Status: ENROLLING_BY_INVITATION